AM J CLIN DERMATOL - American journal of clinical dermatology

Publications

  1. 2023
  2. Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids

    Silverberg, J. I., Armstrong, A., Blauvelt, A. & Reich, K., 11.2023, In: AM J CLIN DERMATOL. 24, 6, p. 913-925 13 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  3. Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies

    Bloudek, L., Eichenfield, L. F., Silverberg, J. I., Joish, V. N., Lofland, J. H., Sun, K., Augustin, M., Migliaccio-Walle, K. & Sullivan, S. D., 01.2023, In: AM J CLIN DERMATOL. 24, 1, p. 109-117 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. 2022
  5. Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis

    Silverberg, J. I., Simpson, E. L., Armstrong, A. W., de Bruin-Weller, M. S., Irvine, A. D. & Reich, K., 01.2022, In: AM J CLIN DERMATOL. 23, 1, p. 1-11 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. 2021
  7. Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments

    Blome, C., Augustin, M. & Klein, T. M., 11.2021, In: AM J CLIN DERMATOL. 22, 6, p. 747-755 9 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  8. 2020
  9. Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study

    Reich, K., Armstrong, A. W., Foley, P., Song, M., Miller, M., Shen, Y. K., You, Y., Han, C. & Gordon, K. B., 12.2020, In: AM J CLIN DERMATOL. 21, 6, p. 881-890 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. 2017
  11. Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders. A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)

    Blauvelt, A., Papp, K. A., Griffiths, C. E. M., Puig, L., Weisman, J., Dutronc, Y., Kerr, L. F., Ilo, D., Mallbris, L. & Augustin, M., 04.2017, In: AM J CLIN DERMATOL. 18, 2, p. 273-280 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. 2016
  13. Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit

    Blome, C., Radtke, M. A., Eissing, L. & Augustin, M., 04.2016, In: AM J CLIN DERMATOL. 17, 2, p. 163-169 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review